http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014005074-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
filingDate 2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3217b2f60345d65156219d96e327531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b099c0dff8360af0ebade61dfaea5e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ccbac738e3b8ae6cb62be2aca85a0de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce47e57a950d1a1fd5eacdf604e0ffe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6118ac6505fd37fcf21d8ad41270e2d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8636ee26b88fefdccf2ac25119dd851c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e0948e4b9e9a380c9c5ef2dccdf812
publicationDate 2014-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2014005074-A
titleOfInvention INHIBITOR OF PROTEIN OF TRANSFER OF ESTERES OF CHOLESTEROL OF OXAZOLIDINONA FUSIONADO.
abstract Compounds that have the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL cholesterol, reducing LDL cholesterol and for treating or preventing atherosclerosis. (see Formula).
priorityDate 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949

Total number of triples: 31.